OPUS Biotech Communications Clients in the News
- BioWorld: Kineta Crafting Seaworthy RIG in Cancer after Merck Sets Sail with German Buy.
- Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery
- Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK
- Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment
- BioWorld: ‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers.
- Inside Perspectives: Gene Editing Takes Center Stage
- WXPress: Will Immunotherapy Knock Out Cancer?
- Inside Perspectives: Will Immunotherapy Knock Out Cancer?
- Inside Perspectives on Cancer Immunotherapy: An Interview with TCR2 Therapeutics CEO Garry Menzel
- Gut Instinct: Leveraging the Microbiome and Human Immune System to Dramatically Transform Medicine
- Inside Perspectives on Cancer Immunotherapy: An Interview with Kineta’s Shawn Iadonato
- Improving the Odds in Cancer With First-Time Immunotherapies
- Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor
